Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis Antimicrobial Resistance February 17, 2022 …
Submit Comments on Draft Policy Statement for BSL-4 Laboratory Verification Biosecurity February 6, 2022 …
Bucknell Researchers Head to Uganda to Study African Bats’ Immune Response to Ebola Virus Biosecurity February 6, 2022 …
NIAID Pandemic Preparedness Plan Aims to Bolster Studies for ‘Prototype’ Pathogens Policy + Initiatives February 6, 2022 …
Complete Protection Against Yersinia pestis by Immunization with Inhalable rF1-V10 Fusion Protein Medical Countermeasures February 2, 2022 …
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment Medical Countermeasures January 31, 2022 …
The U.S. Government Responds to False Allegations Targeted at the DoD Cooperative Threat Reduction Program Biosecurity January 11, 2022 …
DHS Opens Small Business Solicitation for Biological, Chemical Threat Detection CBRNE December 21, 2021 …
Stopping Lethal Anthrax Using an Enzyme to Disrupt the Bacterial Capsule Defense + Military December 8, 2021 …
U.S. Plans to Expand Regional Ebola and Other Special Pathogen Treatment Centers Contracts + Grants October 29, 2021 …
CDC Confirms Bacterial Strain in Aromatherapy Spray Sold at Walmart in Melioidosis Outbreak Outbreak News October 26, 2021 …
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines Contracts + Grants October 21, 2021 …
UTHSC Awarded $3.2 Million for Upgrades to Regional Biocontainment Laboratory Biosecurity October 5, 2021 …
Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine Medical Countermeasures October 4, 2021 …